BLFS Relative Valuation
BLFS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BLFS is overvalued; if below, it's undervalued.
Historical Valuation
BioLife Solutions Inc (BLFS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -621.59. The fair price of BioLife Solutions Inc (BLFS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：24.88
Fair
364.03
PE
1Y
3Y
5Y
Trailing
Forward
41.05
EV/EBITDA
BioLife Solutions Inc. (BLFS) has a current EV/EBITDA of 41.05. The 5-year average EV/EBITDA is 88.98. The thresholds are as follows: Strongly Undervalued below -136.58, Undervalued between -136.58 and -23.80, Fairly Valued between 201.76 and -23.80, Overvalued between 201.76 and 314.53, and Strongly Overvalued above 314.53. The current Forward EV/EBITDA of 41.05 falls within the Historic Trend Line -Fairly Valued range.
742.05
EV/EBIT
BioLife Solutions Inc. (BLFS) has a current EV/EBIT of 742.05. The 5-year average EV/EBIT is -69.66. The thresholds are as follows: Strongly Undervalued below -616.31, Undervalued between -616.31 and -342.98, Fairly Valued between 203.66 and -342.98, Overvalued between 203.66 and 476.99, and Strongly Overvalued above 476.99. The current Forward EV/EBIT of 742.05 falls within the Strongly Overvalued range.
11.31
PS
BioLife Solutions Inc. (BLFS) has a current PS of 11.31. The 5-year average PS is 8.65. The thresholds are as follows: Strongly Undervalued below 1.65, Undervalued between 1.65 and 5.15, Fairly Valued between 12.15 and 5.15, Overvalued between 12.15 and 15.65, and Strongly Overvalued above 15.65. The current Forward PS of 11.31 falls within the Historic Trend Line -Fairly Valued range.
38.64
P/OCF
BioLife Solutions Inc. (BLFS) has a current P/OCF of 38.64. The 5-year average P/OCF is 49.51. The thresholds are as follows: Strongly Undervalued below -161.89, Undervalued between -161.89 and -56.19, Fairly Valued between 155.21 and -56.19, Overvalued between 155.21 and 260.91, and Strongly Overvalued above 260.91. The current Forward P/OCF of 38.64 falls within the Historic Trend Line -Fairly Valued range.
43.40
P/FCF
BioLife Solutions Inc. (BLFS) has a current P/FCF of 43.40. The 5-year average P/FCF is 2.24. The thresholds are as follows: Strongly Undervalued below -992.11, Undervalued between -992.11 and -494.93, Fairly Valued between 499.42 and -494.93, Overvalued between 499.42 and 996.60, and Strongly Overvalued above 996.60. The current Forward P/FCF of 43.40 falls within the Historic Trend Line -Fairly Valued range.
BioLife Solutions Inc (BLFS) has a current Price-to-Book (P/B) ratio of 3.38. Compared to its 3-year average P/B ratio of 2.83 , the current P/B ratio is approximately 19.33% higher. Relative to its 5-year average P/B ratio of 3.15, the current P/B ratio is about 7.20% higher. BioLife Solutions Inc (BLFS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.32%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.50% , the current FCF yield is about -100.00% lower.
3.31
P/B
Median3y
2.83
Median5y
3.15
0.84
FCF Yield
Median3y
-1.32
Median5y
-1.50
Competitors Valuation Multiple
The average P/S ratio for BLFS's competitors is 0.00, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 31.21%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BLFS decreased by 6.05% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -24.31 to -63.99.
The secondary factor is the Revenue Growth, contributed 31.21%to the performance.
Overall, the performance of BLFS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is BioLife Solutions Inc (BLFS) currently overvalued or undervalued?
What is BioLife Solutions Inc (BLFS) fair value?
How does BLFS's valuation metrics compare to the industry average?
What is the current P/B ratio for BioLife Solutions Inc (BLFS) as of Dec 13 2025?
What is the current FCF Yield for BioLife Solutions Inc (BLFS) as of Dec 13 2025?
What is the current Forward P/E ratio for BioLife Solutions Inc (BLFS) as of Dec 13 2025?